New cytometric techniques continue to push the boundaries of multi-parameter 18 quantitative data acquisition at the single-cell level particularly in immunology and 19 medicine. Sophisticated analysis methods for such ever higher dimensional 20 datasets are rapidly emerging, with advanced data representations and 21 dimensional reduction approaches. However, these are not yet standardized and 22 large numbers of measurements are hampered by the difficulties of interpreting 38 high-dimensional datasets and this limits their practical utility. CytoBinning fills the 39 gap of complexity between conventional manual analysis and complex automated 40 analysis to extract deep content in scatter plots which can be later cascaded into 41 more complicated clustering or classification algorithms to obtain novel biological 42 insights. 43
clinical scientists and cell biologists are not yet experienced in their interpretation. 23
More fundamentally their range of statistical validity is not yet fully established. We 24 therefore propose a new method for the automated and unbiased analysis of high-25
dimensional single cell datasets that is simple and robust, with the goal of reducing 26 this complex information into a familiar 2D scatter plot representation that is of 27 immediate utility to a range of biomedical and clinical settings. Using publicly 28 available flow cytometry and mass cytometry datasets we demonstrate that this 29 method (termed CytoBinning), recapitulates the results of traditional manual 30 cytometric analyses and leads to new and testable hypotheses. 31 32 Author Summary 33 The increasingly large number of measurements that can now be made 34 simultaneously using cytometry platforms have created the impression that 2D 35 scatter plots, which used to be the center stage of cytometry data analysis, don't 36 contain enough information. However, sophisticated methods that fully embrace 37 Introduction 44 Cytometry is a multi-parameter single-cell measurement technique that is widely 45 used in biological and clinical studies [1] [2] [3] [4] [5] [6] . One of the main uses of flow cytometry, which has had a major impact across the fields of immunology and medicine, is to differentiate immune cells compositions among cell types or patients. Modern flow 48 cytometers can routinely measure 15-20 cellular markers on millions of cells from 49 dozens of samples in one experiment, and can sort cells into subpopulations based 50 on those markers. Recently mass cytometry has expanded the number of markers 51 that can be measured simultaneously to 100, though the technique is destructive 52 to cells and does not allow for sorting. The conventional way of analyzing flow 53 cytometry data uses a gating strategy which requires the manual selection of 54 regions of interest (ROI) on sequential 2D scatterplots. This type of analysis is very 55 labor intensive and inefficient for such large datasets and also suffers from 56 subjectivity in both the sequence of 2D scatterplots and selection of thresholds 57 (ROI) [3,4,7-10]. Therefore, as both the number of cells analyzed and the number 58 of markers quantified for each cell have grown over the past decade, novel 59 automated and unbiased analysis methods for flow cytometry data are emerging 60 [11] . 61
These novel analysis methods can be divided into two categories based on the 62 problem they address: 1) methods trying to mimic and automatize the process of 63 manual gating [12-18]; and 2) methods trying to identify cell populations using all 64 markers simultaneously without prior biological knowledge [19] [20] [21] [22] . Some cutting-65 edge approaches to automating manual gating, such as flowDensity [16] , are very 66 successful in re-identifying cell subsets that match with manually gated subsets in 67 an automatic, reproducible way. However, gating (both manual and automatic) 68 relies heavily on prior experience to inform the sequence of markers to gate. 69 Furthermore, in gating, researchers must define the cell phenotypes to look for in 70 advance of their analysis, hence hindering discovery of novel cell types and not 71 tapping into the full potential of the acquired data. Gating methods also only 72 explore a very limited portion of the total data space, though unsupervised 73 methods have been published that enhance the efficiency of data usage, with the 74 potential to reveal otherwise hidden differences between datasets [23]. Most 75 unsupervised methods that allow novel cell type discovery aim to identify regions 76 with high cell density in multi-dimensional space [19, 21, [23] [24] [25] [26] [27] [28] [29] [30] . This assumes cells 77 form distinct phenotypes and that only cells inside those relative high-density areas 78 (peaks) are of importance. However, cells that are in between two high-density 79 clusters (valleys) may also have potential biological significance [31] . Another 80 limitation of clustering based methods is that concatenating different samples 81 (which is a widely used strategy [28, 32] ) with potential batch effects can be 82 problematic, hence limiting the meaningful combination datasets across 83 institutions (which is very common in clinical trials). In addition, these clustering 84 based methods require estimation of nearest neighbors in high-dimensional space 85 which suffers from "curse of dimensionality" and may lead to misleading results 86 [33] . As a result, people have been calling for the use of lower dimensional 87 methods such as gating based on 2D scatterplots [34] . 88
In this paper, we present a new method for analyzing cytometry data that utilizes 89 such 2D scatter plots. Instead of gating, we dig deeper into the scatter plots mining 90 the information that are largely bypassed by other methods. This method is useful 91 for the majority of comparative studies that aim to elucidate the difference between 92 two groups of samples. Our method, which we term CytoBinning, identifies the 93 most information rich 2D scatter plots and extracts biological insights from them. 94
We show that biologically relevant differences can be discovered from the pairs of 95 markers identified with this approach. First, we introduce CytoBinning with a 96 synthetic dataset, and then apply it to two public high-dimensional single cell 97 datasets, a flow cytometry dataset comparing composition in immune cells 98 between old and young healthy human donors [21] , and a mass cytometry dataset 99 analyzing the immune signature of eight types of human tissues [35] . 100
Results

101
We synthesized two point-patterns based on the expression of two virtual markers: 102 maker A and marker B. Ten samples were generated for each point-pattern. The 103 first point-pattern, called pattern A, consists of three point-clusters. Two large 104 clusters each contain 5,000 points and a third relatively small cluster contains 105 about 2,000 points. The three clusters are randomly sampled from Gaussian 106 distributions that centered at point (0, 4), (0, -4) and (4, 0) with standard deviation 107 2, 2, and 1 respectively. The second point-pattern, called pattern B, also consists 108 of three point-clusters. The two large clusters are generated in the same way as 109 point-pattern A, however, the third smaller point-pattern only contains 200 to 500 110 points, sampled from a Gaussian distribution centered at point (-4, 6) with standard 111 deviation 1 (Fig. S1 ). 112 Percentile-based binning is a coarse-grained representation of point 123 patterns 124 An example of percentile-based binning is shown in Fig. 1 using one synthetic 125 sample with point-pattern A. Points inside the point-pattern were first binned into 3 levels based on the expression of marker A and B independently, each level 127 containing one third of points. The 3 levels for marker A and B were then combined 128 on a 2D scatter plot to form 9 sub-regions (these sub-regions are called boxes). 129
The percentage of points in each box changes depending on the point-pattern. 130
This binning method has been used as an alternative method to calculate mutual 131 information (MI) in a robust and computationally efficient way [36] . MI is a measure 132 of dependence between two random variables widely used in gene network 133 inference [37] as a general measure of interdependency between genes. In our 134 method, instead of summarizing the binning information into one number (MI), we 135 
146
Applying percentile-based binning to multiple samples enables 147 meaningful classification 148 After we demonstrate how to represent point-patterns with percentile-based 149 binning, next we show that this representation is able to capture real differences in 150 point-patterns. Figure 2A shows two examples of the synthetic point-patterns. In 151 total, 10 samples were generated for each point-pattern, and each sample was 152 analyzed using percentile-based binning to generate the row vectors shown in 153 Figure 2B . Using 3 bins, our method is able to cluster the two point-patterns into 154 distinct groups, and correctly identifies the most significant difference ( Fig. 2B & 155 C). Boxplots of cell percentage in each box show that the box with most distinct 156 difference between the two point-patterns is box B32 which contains the third 157 cluster of point-pattern A (lower panel of Fig. 2B ). This is the most significant 158 difference between these two point-patterns, and it was captured without referring 159 to density distribution of points. Minor differences between these two point-patterns 160 (the small cluster located at the top left corner) were not spotted, since the 161 percentage of points in box B13 is similar in both point patterns ( Fig. 2B ). However, 162 this third cluster in pattern B (~ 2% to 5%), was identified when the number of bins 163 was increased to 6 ( Fig. S2 ). Hence, the depth of analysis depends on the number 164 of bins. 165 
173
The maximum number of bins for binning depends on the number of 174 samples (patients) 175 We've seen in the previous section that the depth of analysis depends on the 176 number of bins used. And here we are going to show that the maximum number 177 of bins we could use depends on the total number of samples (patients), for using 178 a large number of bins to classify a small set of samples would cause overfitting. 179
We see that false positive rate (FPR) increases with the numbers of bins used for 180 binning (Fig. 3A) . However, the maximum number of bins with tolerable FPR (FPR 181 < 0.05) increased when we increase the number of samples from 20 to 60 ( Fig.  182 3a). While with 20 samples we can only use as many as 3 bins to keep FPR under 183 0.05, with 60 samples this number increased to 6. And using 6 bins, our method is 184 able to identify both of the differences we artificially generated between point-185 pattern A and B (Fig. S3 ). To get a general picture of how the maximum number 186 of bins relates to number of samples, we calculated the maximum number of bins 187 with FPR = 0 (we use this stringent condition because i) Synthetic data is easier to 188 classify; ii) Real dataset contains more than 2 markers, and multiple tests 189 correction should be taken into consideration) for various number of samples. We 190 found that when the two groups to be classified contain the same number of 191 samples (patients), the maximum number of bins is around the square root of half 192 the sample size ( Fig. 3B ). In reality, the number of samples (patients) in different 193 groups is rarely equal. However, we can overcome this inequality by assigning 194 different number of samples to cross validation set for different groups so that in 195 training dataset each group will have the same number of samples. Thus, once we 196 know the number of samples in training dataset, we get a reasonable estimate for 197 the number of bins to use. 198 Application to two real human cytometry datasets 199 Next, we applied our method to two real flow cytometry datasets. Both datasets 200 aim to identify differences between two biologically different patients/donor groups. 201
In general, in order to get rid of debris and dead cells, some pre-processing steps 202 should be taken before applying our method (e.g. manual/automatic gating to get 203 live cells). In addition, depends on the question of interest, further gating can be 204 applied to get more focused cell types, e.g. T cells, CD4 + T cells, etc. The pre-205 processed datasets are then the input for our method. We first determine the 206 appropriate number of bins to use based on the number of samples in a dataset. 207
Next, we apply the binning method showing in Figure 1 to the pre-processed 208 dataset. Unlike the simulated dataset showing above which only contains two 209 markers, real cytometry datasets usually measure much more markers which 210 results in even more marker pairs. The binning method is applied to every possible 211 pairs of markers. Then, in order to identify the important marker pairs, we 212 separated the dataset into training and testing subsets. Using a classification 213 algorithm called support vector machine (SVM) [38], we define important marker 214 pairs as the ones that are able to achieve 100% classification accuracy in both 215 training and testing subsets. Once these marker pairs were determined, we move 216 on to identify which regions formed by these marker pairs (boxes) are significantly 217 different between the two groups. 218
Old versus young 219
The first dataset we analyzed aims to find differences in the composition of immune 220 cell types between old and young healthy donors [39] . Peripheral blood 221 mononuclear cell (PBMC) samples from 34 healthy old donors (ages 60 and above) 222 and 22 healthy young donors (ages 19 to 35) were taken, and their cellular 223 composition were quantified by flow cytometry. In total, 16 markers were measured: 224 Ki67, CD95, CD127, CD57, CD3, CD45RA, CD8, CD14, CCR4, CD27, CD11b, 225 PD1, CD4, CD28, CCR7, and a viability dye (live/dead). We first manually gated 226 for the live cells ( Fig. S4 ) which were used as input for our method. At this stage, 227 about 20% of samples (4 young samples and 6 old samples) were randomly 228 chosen as a cross validation set. We determined the optimal number of bins in 229 remaining training dataset to be 5 (as the total number of samples in training set 230 is 46, Fig. 3B ), then we applied SVM classification based on the binning results of 231 all possible pairs of markers. In total, we identified two pairs of markers (CD8 -232 CCR7, CD3 -CD4) that are able to classify old and young donors with 100% 233 accuracy both in training and testing dataset (Fig. S5) . And boxes whose cell 234 percentages are significantly different between old and young donors are identified. 235
We selected the two boxes that are most different between old and young donors 236 for demonstration below, remaining results can be found in supplementary 237 information ( Fig. S6 -S8) . 238
Naï ve CD8 + T cells are found significantly decreased in elderly donors using only 239
CD8 and CCR7 expression. 240
We first look at box B55 which contains cells whose expression of both CD8 and 241 CCR7 are in the top 20% (i.e. CD8 high CCR7 high , Fig. 4A ). We find that percentage 242 of cells inside box B55 decrease significantly in old donors (Fig. 4B ). On the other 243 hand, mean fluorescence intensity (MFI) of cells inside box B55 are similar among 244 donors for all markers, indicating cells inside box B55 are homogeneous across all 245 samples (Fig. 4C ). Notice that CD3 and CD45RA MFI levels are high for all 246 samples, and since cells inside box B55 already express highest 20% of both CD8 247 and CCR7, one possibility is that cells inside B55 are naï ve CD8 + T cells. Indeed, 248 cells in B55 agrees well with manually gated naï ve CD8 cells ( Fig. S9 & S10A) on 249 single cell level. In addition, when comparing the expression of CD45RA and 250 CCR7 between cells in B55 and manually gated CD8 naï ve and memory cell types 251 we find that cells in B55 match well with naï ve cells for young donors with slightly 252 higher variation on CD45RA (Fig. 4D ). Cells in B55 express higher variation in 253 CD45RA for older donors, which is expected since box B55 was selected without 254 expression information of CD45RA (Fig. 5E ). Together, these results suggest that 255 cells inside box B55 resemble naï ve CD8 + T cells. Decreasing of naï ve CD8 + T 256 cells with ageing is a well-known observation in immunology [40] and is also 257 identified in this dataset (Fig. S10B ). In addition, we found that the abundancy of 258 effector memory (TEM) and effector memory RA + (TEMRA) CD8 + T cells are increased in old donors, as suggested by the increased percentage of cells in B51 260 (CD8 high CCR7 low ) ( Fig. S11) . 261 262 
Distinction between naï ve and memory CD8 + T cells is blurred in old donors. 271
Next, we analyzed cells inside box B52 (CD8 high CCR7 intermediate/low ). The 272 percentage of cells inside box B52 (Fig. 5A ) was found to be increased in the old 273 group (Fig. 5B ). Similar to box B55, the MFI of cells in box B52 for all samples were 274 at similar levels for most markers, indicating a homogeneous cell subset is 275 identified among all donors (Fig. 5C ). Notice that box B52 lies in between two 276 peaks ( Fig. 5A) which is a region often neglected or assigned to one of the peaks 277 by manual gating, and we have shown above that cells in peak above B52 (i.e. 278 B55) resemble naï ve CD8 T cells and cells in peak below B52 (i.e. B51) resemble 279 memory CD8 T cells (TEM and TEMRA). We hence infer that cells in B52 are 280 transition cells between naï ve and memory cells which increases with ageing. 
CD4 versus CD8 293
Next, we applied our method to a mass cytometry dataset that originally aims to 294 identify immune signatures among 8 types of human tissues: cord blood, PBMC, 295 liver, spleen, skin, lung, tonsil and colon [35] . There are in total 35 samples, 3 to 6 296 samples for each type of tissue (see Methods). The marker panel used for mass 297 cytometry contains 41 markers with a focus on the function (cytokine expression) 298 of T cells (a full list of all 41 markers can be found in supplementary information 299 and [35] ). Instead of differentiating the 8 types of tissues, here we tried to classify 300 CD4 + cells from CD8 + cells in all types of tissues. This is a good test for our method 301 since there exists great within-group variance (different tissues) in the two groups 302
we're comparing, and we aim to find patterns that are consistent / similar across 303 all types of tissues but are significantly different between CD4 + and CD8 + cells. 304
Like the previous dataset, we divide these tissue samples into training and testing 305 sets as well. From the 35 CD4 samples, 5 samples are randomly selected to be 306 cross validation set; and the same was done for the 35 CD8 samples separately. 307
Since there are in total 60 samples in training set (30 for each cell type), the 308 number of bins to use is 5 (Fig. 3B ). We identified 7 pairs of markers that were able 309 to classify CD4 + and CD8 + cells with 100% accuracy for both training and cross 310 validation datasets. Only 1 marker pair (CCR10 vs. CCR9) out of the 7 contains 311 purely trafficking markers. This indicates that CD4 + and CD8 + T cells can be more 312 easily differentiated by their function and lineage markers than trafficking markers, 313 which is consistent with the results in the original paper [35] . We selected one of 314 the seven marker pairs: Interleukin (IL)-2 vs. CD25 to show in Figure 6 . The pattern 315 formed by CD4 cells is distinct from CD8 cells in that CD4 cells express 316 significantly more IL-2 and slightly more CD25 in all types of tissues, which agrees 317 with previous findings based on circulating immune cells [41] . In addition, we found 318 that percentage of cells in box B13 (red shaded region in Figure 6 , IL-2 low and 319 CD25 intermediate) is significantly higher in CD8 cells, which is a subtle difference 320 that would be missed by algorithms based on a peak finding. The complexity of cytometry data has increased significantly in the last few years 329 due to the advancement in experimental techniques that enable measurements of 330 dozens of parameters on each cell for millions of cells [9] . Novel analysis 331 algorithms are being introduced at a rapid pace to deal with this data deluge that 332 identify clusters of cells and project the high dimensional information graphically in 333 innovative ways. However, these graphics are not directly interpretable and 334 translatable into hypotheses and actions by biomedical researchers and clinicians. 335
There is also the flaw that nearest neighbors are not meaningful in high dimensions, 336 which is a phenomenon referred to as the "curse of dimensionality" [33, 34] . Here 337 we introduce a simpler, alternative approach we term CytoBinning. Our analysis 338 approach combines automation of a more traditional workflow (as advocated in 339
[34]) and machine learning which links the high dimensional data back to two 340 biomarkers which can be represented as 2D scatter plots. The 2D scatter plot 341 outputs are designed to be directly interpretable by biomedical researchers and 342 clinicians, who have an established intuition for the meaning of these graphics. 343
Thus, we are able to leverage their existing expertise in interpreting these kinds of 344 scatterplots. When the differences in phenotype are small, CytoBinning is able to 345 further focus the researcher or clinician's attention by identifying, which specific 346 regions of the scatter plot exhibits the most notable differences between two 347 groups of donors, allowing subtle shifts in the immune phenotype to be highlighted. In the first public dataset we analyzed, which compares lymphocyte populations in 360 old and young healthy donors, CytoBinning automatically discovered a decrease of naï ve CD8 + T cells in the elderly, a well-known yet subtle phenotype. In addition, 362
CytoBinning identified a region in the scatterplot of relatively low cell density 363 between two well-established cell clusters which is clearly increased with ageing 364 as a new area of interest for the biological researcher. Two markers (CD8 and 365 CCR7) are sufficient to pinpoint this subset of cells which resides between naï ve 366 and memory CD8 + T cells, and is not associated with a local peak in cell density in 367 the scatterplot. Such an area would be missed by both manual gating and density-368 based algorithms, or by focusing exclusively on peaks in density. 369
The second public dataset we analyzed was even higher dimensional, based on 370 mass cytometry from eight types of human tissues. CytoBinning analysis of CD4 + 371 vs. CD8 + T cells automatically discovered higher expression of IL-2 in CD4 + T cells 372 as we would expect [41] , and shows that this overexpression is consistent 373 throughout all eight types of human tissues studied. In addition, CytoBinning 374 correctly identified that CD25 is also more highly expressed in CD4 + T cells [41] . 375
This difference in CD25 and IL-2 was consistent among all types of tissues, which 376 is known and therefore obvious to a biological researcher. However, it also 377 demonstrates the power of our method as this marker pair was re-discovered 378 without prior knowledge from a heterogeneous dataset incorporating 35 samples 379 from 8 different tissues, each labelled with 41 markers. Hence, in addition to 380 avoiding the pitfalls of density-based approaches, when applied to very high-381 dimensional datasets CytoBinning is able to select the salient markers which 382 discriminate between groups of samples. 383
In summary, CytoBinning as a robust, automated approach to analyze high 384 throughput cytometry data presented in familiar and interpretable 2D scatter plots. 385
While simultaneous assessment of all markers is an important vision and challenge, 386 in the interim there is a need to facilitate interpretation of high-dimensional data 387
given the evident gap between our technological ability to acquire this information 388 and our ability to understand it. CytoBinning fills the void between conventional 389 manual analysis and complex automated analysis to extract deep content in 390 scatterplots which can be later cascaded into more complicated clustering or 391 classification algorithms to obtain novel biological insights. This has particular potential value in clinical and biological research settings where high-dimensional 393 data is increasingly available and commonly not fully understood. CytoBinning is 394 able to identify the most important markers, while also highlighting novel cell 395 populations that distinguish comparator datasets even if these are to be found in 396 areas of low cell density. Hence, it is a practical analysis approach with potential 397 to fill the complexity gap in interpretation of high-dimensional data in a wide range 398 of biomedical and clinical settings. 399
Methods 400 Binning 401
The binning we used in our method has been previously proposed to estimate 402 Determine appropriate number of bins 415 We deduced a relationship between the maximum number of bins with zero false 416 positive rate (FPR) and the number of samples used in classification using our 417 synthetic data. The relationship we found is: 418
Thus, for a given dataset, an estimation of the number of bins to be used is 420
achieved. In addition, we estimate FPR as follows:
1.
For a given number of bins, apply afore-mentioned binning method to one 422 pair of markers. Each sample is now represented by the vector of P(Ai, Bj). 423
2.
Randomly divide all samples into two groups. 424
3.
Apply SVM classification (ksvm function in R package ks, with linear kernel 425 and C=10) on the randomly divided groups. 426
4.
Repeat step 2 & 3 for 100 iterations, record the frequency when 427 classification accuracy achieved 100% in step 3. 428
5.
Repeat step 1 to 4 for all marker pairs, calculate the mean frequency of one 429 pair achieving 100% accuracy. This frequency is used as an estimation of FPR. 430
6.
Repeat steps above for all numbers of bins. 431
Log ratio transformation 432 The percentages of cells in each box obtained with CytoBinning is compositional 433 as they add up to 100. To get rid of this dependency, we divide the percentages 434 by their median before taking log with base 2 for every sample and every marker 435 pair. 436
Selecting important marker pairs 437 Once the number of bins is determined, we divide all samples into training set 438 (about 80% of total samples) and testing set (the remaining 20% of all samples). 439 SVM is applied to training set and classification boundary obtained for every pair 440 of markers. We use the obtained classification boundary to predict the cross 441 validation set. Pairs that reached 100% accuracy for both training and cross 442 validation datasets are chosen as important marker pairs. 443
Selecting important boxes 444 We combined boxes formed by all selected marker pairs and applied statistical test 445 can be found in [21] . 460
Pre-processing. Downloaded FACS files were first compensated based on the 461 spill matrix in the fcs files, and then manually gated to get live cells ( Fig. S4 ). 462
Logicle transformation was performed with w=0.5, t=262144, and m=4.5 using 463 logicleTransform function in flowCore package with R. 464 Dataset 2: Comparing CD4 and CD8 T cells in various types of tissues 465 The dataset used for demonstration was first published in [35] and downloaded 466 from flow repository website (https://flowrepository.org/) [42] . Tissue types, 467 number of samples, and the reason for surgery are listed in Table 1 . Immune cells 468 were isolated from collected tissues and cryopreserved. They were then thawed 469 and washed for mass cytometry experiment. Two panels of antibodies were used 470 for staining, each containing 41 markers. The two panels were named as "Function" 471 and "Traffic" according to the antibodies included in it. We only used function panel 472 in this paper. Details of experimental process and the lists of antibodies can be 473 found in [35] . The downloaded samples from flow repository are FACS files, pre-474 gated to major immune types (e.g. CD4, CD8, NKT, etc.). We used only CD4 and 475 CD8 cells. We performed logicle transformation using logicleTransform in R 476 package flowCore, with parameters w = 0.25, t= 16409, m =4.5, and a=0 according 477
to [35] . The logicle transformed data were then saved as text files for further 478 analysis. 479 
